Daniela V Luquetti1,2,3, Matthew L Speltz1,2,3, Erin R Wallace1, Babette Siebold1,2, Brent R Collett1,2,3, Amelia F Drake4, Alexis L Johns5, Kathleen A Kapp-Simon6,7, Sara L Kinter1,2, Brian G Leroux8, Leanne Magee9, Susan Norton1,2,3, Kathleen Sie1,2,3, Carrie L Heike1,2,3. 1. 1 Seattle Children's Research Institute, Seattle, WA, USA. 2. 2 Seattle Children's Hospital, Seattle, WA, USA. 3. 3 Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA. 4. 4 University of North Carolina, Chapel Hill, NC, USA. 5. 5 Children's Hospital Los Angeles, Los Angeles, CA, USA. 6. 6 Shriners Hospitals for Children, Chicago, IL, USA. 7. 7 University of Illinois, Chicago, IL, USA. 8. 8 University of Washington School of Dentistry, Seattle, WA, USA. 9. 9 Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Abstract
OBJECTIVE: The Craniofacial microsomia: Longitudinal Outcomes in Children pre-Kindergarten (CLOCK) study is a longitudinal cohort study of neurobehavioral outcomes in infants and toddlers with craniofacial microsomia (CFM). In this article, we review the data collection and methods used to characterize this complex condition and describe the demographic and clinical characteristics of the cohort. SETTING: Craniofacial and otolaryngology clinics at 5 study sites. PARTICIPANTS: Infants with CFM and unaffected infants (controls) ages 12 to 24 months were recruited from the same geographical regions and followed to age 36 to 48 months. METHODS: Phenotypic, neurodevelopmental, and facial expression assessments were completed during the first and third waves of data collection (time 1 and time 3, respectively). Medical history data were taken at both of these time points and during an intermediate parent phone interview (time 2). RESULTS: Our cohort includes 108 cases and 84 controls. Most cases and controls identified as white and 55% of cases and 37% of controls identified as Hispanic. Nearly all cases had microtia (95%) and 59% had mandibular hypoplasia. Cases received extensive clinical care in infancy, with 59% receiving care in a craniofacial clinic and 28% experiencing at least one surgery. Study visits were completed at a study site (92%) or at the participant's home (8%). CONCLUSIONS: The CLOCK study represents an effort to overcome the challenges of characterizing the phenotypic and neurodevelopmental outcomes of CFM in a large, demographically and geographically diverse cohort.
OBJECTIVE: The Craniofacial microsomia: Longitudinal Outcomes in Children pre-Kindergarten (CLOCK) study is a longitudinal cohort study of neurobehavioral outcomes in infants and toddlers with craniofacial microsomia (CFM). In this article, we review the data collection and methods used to characterize this complex condition and describe the demographic and clinical characteristics of the cohort. SETTING:Craniofacial and otolaryngology clinics at 5 study sites. PARTICIPANTS: Infants with CFM and unaffected infants (controls) ages 12 to 24 months were recruited from the same geographical regions and followed to age 36 to 48 months. METHODS: Phenotypic, neurodevelopmental, and facial expression assessments were completed during the first and third waves of data collection (time 1 and time 3, respectively). Medical history data were taken at both of these time points and during an intermediate parent phone interview (time 2). RESULTS: Our cohort includes 108 cases and 84 controls. Most cases and controls identified as white and 55% of cases and 37% of controls identified as Hispanic. Nearly all cases had microtia (95%) and 59% had mandibular hypoplasia. Cases received extensive clinical care in infancy, with 59% receiving care in a craniofacial clinic and 28% experiencing at least one surgery. Study visits were completed at a study site (92%) or at the participant's home (8%). CONCLUSIONS: The CLOCK study represents an effort to overcome the challenges of characterizing the phenotypic and neurodevelopmental outcomes of CFM in a large, demographically and geographically diverse cohort.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: A Jorien Tuin; Youssef Tahiri; Kaitlyn M Paine; J Thomas Paliga; Jesse A Taylor; Scott P Bartlett Journal: Plast Reconstr Surg Date: 2015-01 Impact factor: 4.730
Authors: Daniela V Luquetti; Babette S Saltzman; Daniela Vivaldi; Luiz A Pimenta; Anne V Hing; Cynthia H Cassell; Jacqueline R Starr; Carrie L Heike Journal: Birth Defects Res A Clin Mol Teratol Date: 2012-08-18
Authors: Zakia Hammal; Jeffrey F Cohn; Erin R Wallace; Carrie L Heike; Craig B Birgfeld; Harriet Oster; Matthew L Speltz Journal: Cleft Palate Craniofac J Date: 2018-01-29
Authors: C L Heike; A V Hing; C A Aspinall; S P Bartlett; C B Birgfeld; A F Drake; L A Pimenta; K C Sie; M M Urata; D Vivaldi; D V Luquetti Journal: Am J Med Genet C Semin Med Genet Date: 2013-10-16 Impact factor: 3.908
Authors: Carrie L Heike; Laura P Stueckle; Erik T Stuhaug; Luiz A Pimenta; Amelia F Drake; Daniela Vivaldi; Kathleen C Y Sie; Craig B Birgfeld Journal: Head Face Med Date: 2011-12-30 Impact factor: 2.151
Authors: Craig B Birgfeld; Carrie L Heike; Babette S Saltzman; Brian G Leroux; Kelly N Evans; Daniela V Luquetti Journal: Head Face Med Date: 2016-03-31 Impact factor: 2.151
Authors: Babette Siebold; Carrie L Heike; Brian G Leroux; Matthew L Speltz; Amelia F Drake; Alexis L Johns; Kathleen A Kapp-Simon; Leanne Magee; Daniela V Luquetti Journal: Birth Defects Res Date: 2019-03-30 Impact factor: 2.344
Authors: Alexis L Johns; Erin R Wallace; Brent R Collett; Kathleen A Kapp-Simon; Amelia F Drake; Carrie L Heike; Sara L Kinter; Daniela V Luquetti; Leanne Magee; Susan Norton; Kathleen Sie; Matthew L Speltz Journal: Cleft Palate Craniofac J Date: 2020-08-12